BSX vs POST · P/E 20, rev $16.75B vs P/E 15, rev $8.16B
Boston Scientific Corp (BSX) versus Post Holdings Inc (POST) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Post Holdings Inc (POST) is a packaged foods company listed on NYSE.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported POST revenue for 2025-09-30 was $8.16B. Net income was $335.8M. Revenue was up 3.0% from 2024-09-30 to 2025-09-30. POST currently screens at market cap $4.03B and trailing P/E 14.9.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. POST currently screens at market cap $4.03B and trailing P/E 14.9.
Not investment advice. Open the BSX and POST stock pages for the full models.
Not investment advice.